Photo from wikipedia
The safety and effectiveness of edoxaban in real‐world clinical settings have not yet been elucidated thoroughly among Japanese patients with nonvalvular atrial fibrillation (NVAF). We report the one‐year interim results… Click to show full abstract
The safety and effectiveness of edoxaban in real‐world clinical settings have not yet been elucidated thoroughly among Japanese patients with nonvalvular atrial fibrillation (NVAF). We report the one‐year interim results of ETNA‐AF‐Japan (Edoxaban Treatment in routiNe clinical prActice in patients with nonvalvular Atrial Fibrillation: UMIN000017011), an ongoing two‐year study.
Keywords:
atrial fibrillation;
nonvalvular atrial;
year;
safety effectiveness;
patients nonvalvular
Journal Title: Journal of Arrhythmia
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Arrhythmia
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!